Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology

Authors

Philip R. Cohen, Touro University CaliforniaFollow
R. Kurzrock

Roles

Author

Document Type

Article

Publication Date

1-1-2022

Recommended Citation

Cohen, P. R., & Kurzrock, R. (2022). Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology. Dermatology and Therapy, 12 (10), 2249-2271. https://doi.org/10.1007/s13555-022-00801-2